Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Multiple Sclerosis

  Free Subscription


1 Acta Neurol Scand
1 J Clin Invest
2 J Neurol
1 Mult Scler
1 Neurologia (Engl Ed)
2 Neurology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. SILVA GD, Castrillo BB, Apostolos-Pereira SL, Callegaro D, et al
    Is there a role for off-label high-efficacy disease-modifying drugs in progressive multiple sclerosis? A network meta-analysis.
    Acta Neurol Scand. 2022 Sep 2. doi: 10.1111/ane.13697.
    PubMed         Abstract available

    J Clin Invest

  2. HORWITZ RI, Hayes-Conroy A, Singer BH, Cullen MR, et al
    Falling down the biological rabbit hole: Epstein-Barr virus, biography, and multiple sclerosis.
    J Clin Invest. 2022;132.

    J Neurol

  3. CAPASSO N, Palladino R, Cerbone V, Spiezia AL, et al
    Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study.
    J Neurol. 2022 Sep 1. pii: 10.1007/s00415-022-11350.
    PubMed         Abstract available

  4. WOELFLE T, Pless S, Reyes O, Wiencierz A, et al
    Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study.
    J Neurol. 2022 Aug 30. pii: 10.1007/s00415-022-11306.
    PubMed         Abstract available

    Mult Scler

  5. PORTACCIO E, Amato MP
    Reliable change indices for cognitive assessment of patients with multiple sclerosis.
    Mult Scler. 2022 Sep 1:13524585221116273. doi: 10.1177/13524585221116273.

    Neurologia (Engl Ed)

  6. MIRMOSAYYEB O, Shaygannejad V, Ebrahimi N, Ghoshouni H, et al
    The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis.
    Neurologia (Engl Ed). 2022 Aug 30. pii: S2173-5808(22)00090.
    PubMed         Abstract available


  7. CORDANO C, Nourbakhsh B, Yiu HH, Papinutto N, et al
    Differences in Age-Related Retinal and Cortical Atrophy Rates in Multiple Sclerosis.
    Neurology. 2022 Aug 29. pii: WNL.0000000000200977.
    PubMed         Abstract available

  8. VILLOSLADA P, Llufriu S
    Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease.
    Neurology. 2022 Aug 29. pii: WNL.0000000000201223.

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.